204 related articles for article (PubMed ID: 35471002)
1. [Monoclonal gammopathies and kidney: a diagnostic challenge without any clues].
Schiavone G; Catapano F; Ratto E; Fabbrizio B; Mancini E
G Ital Nefrol; 2022 Apr; 39(2):. PubMed ID: 35471002
[TBL] [Abstract][Full Text] [Related]
2. [Paraprotein-related kidney disease. Experience in 22 cases].
Jerez J; Juanet C; Sharp J; Ernst D; Méndez GP; Sepúlveda RA
Rev Med Chil; 2020 Aug; 148(8):1059-1067. PubMed ID: 33399771
[TBL] [Abstract][Full Text] [Related]
3. The Complexity and Heterogeneity of Monoclonal Immunoglobulin-Associated Renal Diseases.
Sethi S; Rajkumar SV; D'Agati VD
J Am Soc Nephrol; 2018 Jul; 29(7):1810-1823. PubMed ID: 29703839
[TBL] [Abstract][Full Text] [Related]
4. [Diagnosis and treatment of kidney involvement in plasma cell diseases : Renal involvement in multiple myeloma and monoclonal gammopathies].
Gödecke V; Schmidt JJ; Bräsen JH; Koenecke C; Haller H
Internist (Berl); 2019 Jan; 60(1):10-22. PubMed ID: 30635666
[TBL] [Abstract][Full Text] [Related]
5. Clinicopathological characteristics of patients with paraproteinemia and renal damage.
Tang X; Wan F; Yu J; Li X; Yang R; Zhu B
Eur J Med Res; 2021 Jul; 26(1):68. PubMed ID: 34217367
[TBL] [Abstract][Full Text] [Related]
6. Monoclonal gammopathies of renal significance.
Gnanasampanthan S; Kousios A
Clin Med (Lond); 2023 May; 23(3):250-253. PubMed ID: 37236803
[TBL] [Abstract][Full Text] [Related]
7. The evaluation of monoclonal gammopathy of renal significance: a consensus report of the International Kidney and Monoclonal Gammopathy Research Group.
Leung N; Bridoux F; Batuman V; Chaidos A; Cockwell P; D'Agati VD; Dispenzieri A; Fervenza FC; Fermand JP; Gibbs S; Gillmore JD; Herrera GA; Jaccard A; Jevremovic D; Kastritis E; Kukreti V; Kyle RA; Lachmann HJ; Larsen CP; Ludwig H; Markowitz GS; Merlini G; Mollee P; Picken MM; Rajkumar VS; Royal V; Sanders PW; Sethi S; Venner CP; Voorhees PM; Wechalekar AD; Weiss BM; Nasr SH
Nat Rev Nephrol; 2019 Jan; 15(1):45-59. PubMed ID: 30510265
[TBL] [Abstract][Full Text] [Related]
8. Spectrum of manifestations of monoclonal gammopathy-associated renal lesions.
Sethi S; Fervenza FC; Rajkumar SV
Curr Opin Nephrol Hypertens; 2016 Mar; 25(2):127-37. PubMed ID: 26735145
[TBL] [Abstract][Full Text] [Related]
9. Monoclonal gammopathies of renal significance.
Caravaca-Fontán F; Gutiérrez E; Delgado Lillo R; Praga M
Nefrologia; 2017; 37(5):465-477. PubMed ID: 28946960
[TBL] [Abstract][Full Text] [Related]
10. Monoclonal Gammopathy-Related Kidney Diseases.
Sy-Go JPT; Herrmann SM; Seshan SV
Adv Chronic Kidney Dis; 2022 Mar; 29(2):86-102.e1. PubMed ID: 35817530
[TBL] [Abstract][Full Text] [Related]
11. Crystalglobulin-associated nephropathy presenting as MGRS in a case of monoclonal B-cell lymphocytosis: a case report.
Gupta RK; Arend LJ; Bk A; Narsipur S; Bhargava R
BMC Nephrol; 2020 May; 21(1):184. PubMed ID: 32423442
[TBL] [Abstract][Full Text] [Related]
12. Updates in Plasma Cell Dyscrasias and Related Monoclonal Immunoglobulin-Mediated Renal Disease.
Midha S; Nadeem O; Selamet U
Semin Nephrol; 2022 Nov; 42(6):151352. PubMed ID: 37257390
[TBL] [Abstract][Full Text] [Related]
13. Monoclonal gammopathy of renal significance: Spectrum of diseases and approach to a case.
Tewari R; Chatterjee T; Mendonca S; Dogra M; Pramanik SK; Yanamandra U
Saudi J Kidney Dis Transpl; 2021; 32(2):298-306. PubMed ID: 35017322
[TBL] [Abstract][Full Text] [Related]
14. Proliferative glomerulonephritis with monoclonal immunoglobulin deposits: a nephrologist perspective.
Bridoux F; Javaugue V; Nasr SH; Leung N
Nephrol Dial Transplant; 2021 Jan; 36(2):208-215. PubMed ID: 33494099
[TBL] [Abstract][Full Text] [Related]
15. Laboratory testing in monoclonal gammopathy of renal significance (MGRS).
Leung N; Barnidge DR; Hutchison CA
Clin Chem Lab Med; 2016 Jun; 54(6):929-37. PubMed ID: 27107835
[TBL] [Abstract][Full Text] [Related]
16. [Classification and Management of MGRS Related Diseases].
Angioi A; Lepori N; Derudas D; Floris M; Mascia G; Cabiddu G; Pani A
G Ital Nefrol; 2023 Oct; 40(Suppl 81):. PubMed ID: 38007837
[TBL] [Abstract][Full Text] [Related]
17. Monoclonal gammopathy of renal significance: when MGUS is no longer undetermined or insignificant.
Leung N; Bridoux F; Hutchison CA; Nasr SH; Cockwell P; Fermand JP; Dispenzieri A; Song KW; Kyle RA;
Blood; 2012 Nov; 120(22):4292-5. PubMed ID: 23047823
[TBL] [Abstract][Full Text] [Related]
18. Kidney Histopathologic Spectrum and Clinical Indicators Associated with MGRS.
Yong ZH; Yu XJ; Liu JX; Zhou FD; Wang SX; Zhao MH
Clin J Am Soc Nephrol; 2022 Apr; 17(4):527-534. PubMed ID: 35210280
[TBL] [Abstract][Full Text] [Related]
19. A clone-directed approach may improve diagnosis and treatment of proliferative glomerulonephritis with monoclonal immunoglobulin deposits.
Gumber R; Cohen JB; Palmer MB; Kobrin SM; Vogl DT; Wasserstein AG; Nasta SD; Bleicher MB; Bloom RD; Dember L; Cohen A; Weiss BM; Hogan JJ
Kidney Int; 2018 Jul; 94(1):199-205. PubMed ID: 29759418
[TBL] [Abstract][Full Text] [Related]
20. [Classification and therapeutic management of monoclonal gammopathies of renal significance].
Javaugue V; Bouteau I; Sirac C; Quellard N; Diolez J; Colombo A; Desport E; Ecotière L; Goujon JM; Fermand JP; Touchard G; Jaccard A; Bridoux F
Rev Med Interne; 2018 Mar; 39(3):161-170. PubMed ID: 28457684
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
